Pages
Posts
- Brace will be attending the H.C. Wainwright 22nd Annual Global Investment Virtual Conference on September 14-16
- Brace will be attending the Wedbush Pacgrow Healthcare Conference in New York City from August 11-12, 2020
- Brace will be attending the Wedbush Pacgrow Healthcare Conference in New York City from August 13-14, 2019
- Brace will be attending the Jefferies 2019 Global Healthcare Conference in New York City from June 4-7, 2019
- Brace will be attending RESI Philadelphia on June 3, 2019
- Lilly and Avidity Biosciences Announce Licensing and Research Collaboration
- Brace will be attending the World Orphan Drug Congress USA in Oxon Hill, MD from April 11-12, 2019
- Brace will be attending the Cowen & Company 39th Annual Healthcare Conference in Boston, MA from March 11-March 13, 2019
- Brace will be attending the Leerink Partners Annual Global Healthcare Conference in New York from February 27-March 1, 2019
- Brace will be attending the JP Morgan Healthcare Conference in San Fransisco from January 7-10, 2019
- Brace will be attending the RESI New York Conference on November 5 in New York City
- Brace will be attending BIO-Europe in Denmark November 5-7, 2018
- Brace will be attending the Cowen & Co Therapeutics Conference on October 9th and 10th in New York City
- Brace will be attending the BIO Investor Forum on October 17th and 18th in San Francisco, CA
- Brace will be attending the BioPharm America Conference on September 5-6 in Boston, MA
- Brace will be attending the RESI Boston Conference on September 6 in Boston, MA
- UNUM THERAPEUTICS ANNOUNCES ACTIVE INVESTIGATIONAL NEW DRUG (IND) APPLICATION FOR ANTIBODY-COUPLED T CELL RECEPTOR (ACTR) PLATFORM IN COMBINATION WITH TRASTUZUMAB IN PATIENTS WITH HER2+ ADVANCED CANCERS
- ReViral announces Series B investment
- Brace will be attending the Wedbush PacGrow Healthcare Conference on August 15-16 in New York City
- Brace will be attending The Oppenheimer Newport Summit for Revolutionary Biotechnology in Newport, RI on August 12-13, 2018
- Unum Therapeutics to Present Pre-Clinical Data on its Antibody-Coupled T Cell Receptor (ACTR) Platform at the American Society of Hematology (ASH) Summit on Emerging Immunotherapies for Hematological Diseases
- Miragen Therapeutics Announces Initiation of Phase 2 Clinical Trial of MRG-201
- Antiva Biosciences Closes $15 Million Series C-1 Financing
- Precision BioSciences Raises $110M to Advance ARCUS Genome Editing Programs
- Brace will be attending the Jefferies 2018 Global Healthcare Conference from June 5-8, 2018 in New York
- Brace will be attending the American Society of Gene & Cell Therapy Meeting in Chicago on May 15-18, 2018
- Brace will be attending the World Orphan Drug Congress in Washington DC on Apr 26-27th, 2018
- Brace will be attending the BioHealth Capital Region Forum in Gaithersburg, MD on Mar 23-24, 2018
- Brace will be attending the Cowen Health Care Conference in Boston from Mar 12-14, 2018
- Brace will be attending the Leerink Partners Global Healthcare Conference in New York on Feb 14-15, 2018
- Brace will be attending the 2018 BIO CEO & Investor Conference in New York on Feb 12-13, 2018
- Brace will be attending the JP Morgan Healthcare Conference in San Fransisco from January 8-11 2017
- Brace will be attending the Piper Jaffray 29th Annual Healthcare Conference in New York from November 28-29 2017
- Brace will be attending BIO Europe in Berlin, Germany on Nov 6-8, 2017
- Dr. Raymond Schinazi Appointed as Affiliated Professor of the Institut Pasteur
- Brace will be attending the BIO Investor Forum in San Francisco on Oct 17-28, 2017
- Brace will be attending the Biopharm America Conference in Boston on Sep 25-27, 2017
- Brace will be attending the RESI Boston Conference in Boston on Sep 26 2017
- Brace will be attending the Rodman & Renshaw 19th Annual Global Investment Conference in New York on Sep 11, 2017
- Brace will be attending the 2017 Wedbush Pacgrow Healthcare Conference in New York on Aug 15-16, 2017
- Brace will be attending the Jefferies 2017 Global Healthcare Conference in New York on June 6-9, 2017
- Brace will be attending the UBS Global Healthcare Conference in New York on May 22-23, 2017
- Brace will be attending the BIO International Convention in San Diego on June 19-21, 2017
- Brace will be attending RESI San Diego on June 19, 2017
- Zymeworks Files Registration Statement For Proposed Initial Public Offering
- Antiva Biosciences Closes $22 Million Series C Financing
- Brace will be attending the Cowen and Company Healthcare Conference in Boston on March 8th, 2017
- Brace will be attending the Leerink Partners Healthcare Conference in New York on February 15-16, 2017
- Brace will be attending the BIO CEO & Investor Forum in New York on February 13-14, 2017
- Dr. Raymond Schinazi Wins the Lifetime Achievement Award at the 12th Annual Scrip Awards
- Brace will attending the 35th annual J.P. Morgan Healthcare Conference in San Francisco from January 9-11, 2016
- Brace will attending the Biotech Showcase 2017 Conference in San Francisco from January 9-11, 2016
- Brace will attending the RESI Conference in San Francisco on January 9, 2016
- Brace will be attending the 28th annual Piper Jaffray Healthcare Conference in New York
- Brace will be attending the BIO Europe in Cologne, Germany on November 7-11, 2016
- Institute of Human Virology honors Dr. Raymond Schinazi with Lifetime Achievement Award
- Zymeworks Doses First Patient in Phase 1 Trial of ZW25, a Novel Bi-Specific Antibody
- Brace will be attending the BIO Investor Forum in San Francisco on October 18-19 2016
- Brace will be attending the Cell & Gene Therapy meeting on October 5-7th 2016
- Brace will be attending RESI Boston on September 13th, 2016
- F2G Ltd Announces $60 Million Financing to Progress Development of Novel Antifungal Agents
- Brace will be attending the Redefining Early Stage Investments (RESI) Conference June 23, 2016
- Brace will be attending the Jefferies 2016 Healthcare Conference June 7-10, 2016
- Brace will be attending the World Orphan Drug Congress April 20-22
- Brace will be attending the RESI Houston Conference on April 11
- Brace will be attending Cowen and Company\’s 36th Annual Healthcare Conference March 7- 9, 2016
- Zymeworks Announces $61.5 Million Financing to Support the Clinical Development of its Pipeline
- Navitor Pharmaceuticals Announces $33 Million Series B Financing
- Brace will be attending the BIO CEO & Investor Forum in New York
- Brace will be attending the Cell & Gene Therapy Forum 2016 in Washington DC
- Brace will be attending the JP Morgan Healthcare Conference 2016 in San Francisco
- Brace will be attending the Biotech Showcase 2016 conference in San Francisco
- Brace will be attending the RESI Conference in San Francisco
- miRagen Therapeutics Secures $41 million Series C Financing to Advance Two MicroRNA Programs into Clinical Trials
- Therabron Therapeutics Receives Accelerated Second Tranche from Series B Financing and Expands Investor Syndicate
- Brace will be attending the Piper Jaffray Healthcare Conference in New York
- Brace will be attending the Jefferies Global Healthcare Conference
- Brace will be attending the World Orphan Drug Congress Europe 2015
- Brace will be attending BIO Europe 2015
- ReViral announces US$21 million fundraising to advance clinical development of a novel anti-viral drug
- Brace will be attending Life Science Nation\’s RESI Conference in Boston
- Brace will be attending the 17th Annual Rodman & Renshaw Global Investment Conference
- Brace will be attending the Stem Cells Regenerative Medicine Congress 2015
- Raymond Schinazi, Drug-development Pioneer, Earns VA\’s Highest Honor for Biomedical Research
- Brace will be attending the 14th Annual BIO Investor Forum in San Francisco
- Unum Therapeutics Announces $65 Million Series B Financing Round
- Brace will be attending the 2015 BIO Convention
- Brace will be Attending the RESI Conference in Houston, Texas
- Brace will be Attending the Jefferies 2015 Healthcare Conference
- Brace will be Attending the World Orphan Drug Congress 2015
- Brace will be Attending the Leerink Global Healthcare Conference 2015
- Brace Will be Attending The 17th Annual BIO CEO & Investor Forum 2015
- Brace Will be Attending Phacilitate\’s Cell and Gene Therapy Forum 2015
- American Liver Foundation awards Emory inventor with Distinguished Scientific Achievement Award
- Brace Will be Attending EBD Group\’s Biotech Showcase 2015
- Brace Will Be Attending JP Morgan\’s 33rd Annual Healthcare Conference
- Brace Will Be Attending Piper Jaffray\’s 26th Annual Global Healthcare Conference
- Brace Pharmaceuticals is pleased to announce it\’s investment in Tyrogenex Inc
- Brace will be attending the JP Morgan\’s 32nd Annual Healthcare Conference in San Francisco, California, January 13-16. 2014
- Brace Pharmaceutical is pleased to announce its venture with Gliknik
- Brace Pharmaceuticals plans to invest $200 Million into Maryland
- Brace has become a member of NORD
- Brace will be attending the Jefferies Global Healthcare Conference
- Brace has established its home in a State of the Art facility at RIC